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Abstracts / Urological Science 26 (2015) S36eS49S40Results: There was signiﬁcant difference in intravesical pressure and inter-
contraction interval when rats treated with chitosan. Systemic cytokines
including IL-6andTNF-a increased inCYPratswhile IL-10and IFN-rdecreased.
The trend is mildly reversed in IL-10 when intravesical chitosanwas applied.
Conclusions: Chitosan may potentiate the effect of cyclophosphamide.
Spleen cytokines changes indicated that locally applied chitosanmay affect
systemic response in rats. Intravesical chitosan had a role further more
than a coating agent in bladder.
MP2-7.
IDENTIFYING THE VARIABLES ASSOCIATED WITH PAIN DURING
TRANSRECTAL ULTRASONOGRAPHY OF THE PROSTATE
Chen-Pang Hou MD, Phei-Lang Chang MD, Chien-Lun Chen MD, PhD, Yu-
Hsiang Lin MD, Chou Chih-Yuan, Ke-Hung Tsui MD. Department of Urology,
Chang Gung Memorial Hospital, Taoyuan, Taiwan
Purpose: The purpose of this study was to prospectively investigate the
degree of pain experienced by patients receiving transrectal ultrasonog-
raphy (TRUS) of the prostate by applying a visual analogue scale (VAS). We
also identiﬁed the clinical parameters inﬂuencing pain during the TRUS
examination.
Materials and methods: Records were obtained from a prospective
database for male patients who received TRUS of prostate in the outpatient
department of Chang-Gung Memorial Hospital, Taiwan, from January 2014
to June 2014. The patients underwent a detailed physical examination and
medical history review. Immediately after the TRUS examination, the pa-
tients completed questionnaires based on a 10-point visual analogue pain
scale. The variables of interest were age, body mass index, prostate vol-
ume, prostate sagittal length, prostatic speciﬁc antigen, previous TRUS
experience, external hemorrhoids, anal surgical history, prostate calciﬁ-
cation, and image artifact caused by stool in the rectum. All variables were
correlated to the VAS by applying multivariate regression analysis.
Results: By using linear regression analysis, we identiﬁed the independent
factors that affected the pain score during the TRUS examination. The
patients who received the examination for the ﬁrst time or had longer
prostate sagittal lengths, external hemorrhoids, anal surgical history, or
stool stored in the rectum all experienced more pain during the TRUS
examination. Furthermore, the pain was reduced when we provided the
patients with a detailed explanation before the procedure and allowed
them to observe the real-time image during the examination
Conclusions: Although a TRUS examination is uncomfortable for patients,
after having identiﬁed the factors affecting pain, physicians can assist
patients in reducing pain during the procedure, thus providing higher
quality examinations.Female Urology & Urodynamics
MP2-8.
INCREASED RISK OF ISCHEMIC STROKE AMONG WOMEN WITH
BLADDER PAIN SYNDROME/INTERSTITIAL CYSTITIS: A COHORT STUDY
FROM TAIWAN
Shiu-Dong Chung 1,2, Sudha Xirasagar 3, Ching-Chun Lin 4, Wells
Ling 5, Hsien-Chang Li 6, Herng-Ching Lin 2,6,*. 1Division of Urology,
Department of Surgery, Far Eastern Memorial Hospital, Ban Ciao, Taipei,
Taiwan; 2 Sleep Research Center, Taipei Medical University Hospital, Taipei,
Taiwan; 3Arnold School of Public Health, Department of Health Services
Policy and Management, University of South Carolina, Columbia, South
Carolina, USA; 4Department of Psychology, Saint Louis University, St. Louis,
Missouri, USA; 5Graduate Institute of Biomedical Informatics, College of
Medical Science and Technology, Taipei Medical University, Taipei, Taiwan;
6 School of Health Care Administration, Taipei Medical University, Taipei,
Taiwan
Purpose: Vascular factors are proposed in the etiology of bladder pain
syndrome/interstitial cystitis (BPS/IC). In this study, we investigated the* Corresponding author.risk of stroke among women following a diagnosis of BPS/IC over 3 years of
follow-up, compared to controls without a BPS/IC diagnosis.
Materials and methods: This retrospective cohort study used data
retrieved from the Taiwan ‘‘Longitudinal Health Insurance Database 2000.’’
We identiﬁed 847 women who received a diagnosis of BPS/IC between
January 1, 2001 and December 31, 2008 (study group) and 4,235 com-
parison women (women without a BPS/IC diagnosis matched on age and
other selected demographic variables. All subjects were tracked for 3 years
following the index date to identify those who received a diagnosis of
stroke during follow-up.
Results: The stroke incidence rate was 20.86 (95% conﬁdence interval (CI):
15.78e27.07) and 11.65 (95% CI: 9.88e13.64) per 1,000 person-years
among the study and comparison cohorts, respectively. Cox regression
analysis showed a stroke hazard ratio (HR) of 1.52 (95% CI: 1.09e2.14) in
the BPS/IC group relative to the comparison group over 3-year follow-up,
after adjusting for hypertension, diabetes, coronary heart disease, atrial
ﬁbrillation, hyperlipidemia, and chronic kidney disease. The adjusted HR of
ischemic stroke was 1.52 (95% CI: 1.02e2.27). However, there was no
signiﬁcant difference between the two groups in hemorrhagic stroke risk.
Conclusions: Our study demonstrates an association between BPS/IC and
a subsequent ischemic stroke diagnosis among women in Taiwan. Neuro-
urol. Urodynam. 34:44e49, 2015. # 2013 Wiley Periodicals, Inc.
MP2-9.
PRIMARY EXPERIENCES OF SINGLE INCISION MIDURETHRAL SLING IN
WOMEN WITH STRESS URINARY INCONTINENCE
Chia-Shen Chien, Yuan-Chi Shen, Yao-Chi Chuang. Department of Urology,
Chang Gung Memorial Hospital-Kaohsiung Medical Center, Chang Gung
University College of Medicine, Kaohsiung, Taiwan
Purpose: We present our preliminary experience of single-incision mid-
urethral sling (ADJUST and MiniArc) in women with stress urinary incon-
tinence (SUI).
Materials and methods: Four patients had mixed urinary incontinence
(MUI) and the other 4 had only SUI, while one of them had concomitant
cystocele. Half of the patients with MUI and SUI received ADJUST while
MiniArc was applied for the others. Cystocele was repaired simultaneously
with anterior Elevate system. Subjective cure was deﬁned as no report of
leakage with coughing or exercise on validated International Consultation
on Incontinence Questionnaire-Urinary Leakage-Short Form (ICIQ-UI-SF).
Operation time, Foley indwelling time, hospital stay, perioperative post-
void residual urine (PVR) and uroﬂow study were documented as well.
Results: Signiﬁcant subjective improvement of urinary incontinence was
observed in all patient groups. Only one patient had prominent PVR
(110ml) after ADJUST sling surgery but no eminent decrease of Qmax.
Another patient self-reported as symptoms improvement instead of cure
due to persistent urinary urgent incontinence (UUI). MiniArc claimed
shorter operation time (from 10min to 20min), while ADJUST sling needed
a longer operation time (from 20 min to 30 min). Foley was removed one
day after operation except in patient with combined cystocele repaired
(Foley removed 2 days after operation).
Conclusion: The current primary results showed optimal outcome of
subjective improvement in patients with SUI or MUI with mean follow up
between 1 month to 1 year. Modern single incision sling is easy to perfrom
without signiﬁcant complications. Further objective outcomes and longer
follow-up are needed to draw the conclusions.
MP2-10.
INTERSTITIAL CYSTITIS/BLADDER PAIN SYNDROME (IC/BPS) IS NOT
RELATED TO BLADDER CANCER: A NATIONWIDE POPULATION-BASED,
PROPENSITY SCOREeMATCHED COHORT STUDY
Ming-Huei Lee 1,2, Wei-Chih Chen 1, Huei-Ching Wu1,2. 1Department of
Urology, Fong Yuan Hospital, Ministry of Health and welfare, Taiwan;
2Central Taiwan University of Science and Technology, Taiwan
Purpose: Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS) is a highly
prevalent debilitating chronic condition characterized by bladder pain and
Abstracts / Urological Science 26 (2015) S36eS49 S41urinary symptoms such as frequency, urgency, and nocturia. Previous
study reported that patients with IC/BPS during the 3-year follow-up
period showed increased risk of bladder cancer than healthy controls.
However, a potential detection bias may exist when elevated risk for
bladder cancer within three years immediately following an IC/BPS diag-
nosis. There should be noted that it is also common for IC/BPS to coexist
with either unexplained medical conditions, such as ﬁbromyalgia, irritable
bowel syndrome, and chronic fatigue syndrome or confusable diseases
during diagnosis of IC/BPS, such as urolithiasis and urinary tract infection.
Therefore, we re-examined the risk of bladder cancer in a large population
based cohort of individuals with a new diagnosis of IC/BPS to assess a
potential detection bias.
Materials and methods: We performed a retrospective cohort study of
Longitudinal Health Insurance Database 2000 with newly diagnosis of IC/
BPS from 2002 through 2010. After limiting our sample to patients with IC/
BPS diagnosis (ICD-9 code 595.1 at least once during the study period), we
identiﬁed an IC/BPS cohort. We then excluded patients with diagnosis of
bladder cancer (ICD-9 codes, 180-189) before IC/BPS diagnosis. The pri-
mary outcome was the event of bladder cancer, determined by the record
with ICD-9 codes, 180-189 after the entry dates. We deﬁned the logit of
predicted probability of bladder cancer as a propensity score using the
following baseline characteristics: sex, age, date of diagnosis, comorbidity,
and smoking status. Subjects with IC/BPS were matched on a one-to one
basis with subjects with non-IC/BPS. We used chi-square tests to evaluate
associations between events of bladder cancer and patient-level covariates
(age, sex, comorbidity, smoking status). Next, we compared primary
outcome (events of bladder cancer) between IC/BPS and non-IC/BPS cohort
using multiple logistic regression. Analyses were performed using SPSS
version 22.
Results: After adjusted with propensity score-matching, we identiﬁed
1642 patients with diagnosis of IC/BPS and 1642 patients with non-IC/BPS
cohort. There is no statistically signiﬁcant association between comor-
bidity and bladder cancer except urolithiasis (P < 0.001) and urinary tract
infection (P ¼ 0.03). During the study period, 20 (1.2%) IC/BPS patients and
30 (1.8%) non-IC/BPS patients were diagnosed as having bladder cancer.
Chi-square test showed no difference of bladder cancer incidence between
IC/BPS and non-IC/BPS cohort (p ¼ 0.2). Moreover, the multiple logistic
regressions estimating the risk of bladder cancer showed no signiﬁcant
association among IC/BPS, sex, urolithiasis, and urinary tract infection
except age (B ¼ 0.02, p ¼ 0.005).
Conclusions: Our results imply us that IC/BPS is not related to bladder
cancer. The detection bias from previous study may be the results of either
an inadequate matching non-IC/BPS cohort or poor controlled confound-
ing factor.Moderated Poster-3Urolithiasis
MP3-1.
COMPARISON OF EFFICACY OF URETEROSCOPIC LITHOTRIPSY BETWEEN
PNEUMATIC LITHOCLAST AND HOLMIUM LASER IN MANAGEMENT OF
UPPER URETERAL STONE
Li-Chen Chen, Marcelo Chen, Wun-Rong Lin, Wen-Chou Lin, Huang-Kuang
Chang, Stone Yang, Jong-Ming Hsu, Wei-Kung Tsai, Pai-Kai Chiang, Yung-
Chiong Chow. Department of Urology, Mackay Memorial Hospital, Taipei,
Taiwan
Purpose: To evaluate the efﬁcacy of ureteroscopic lithotripsy with pneu-
matic lithoclast and laser in management of upper ureteral stones.
Materials and methods: We retrospectively review the medical record.
Patients who underwent ureteroscopic lithotripsy by pneumatic lithoclast
and laser between January 2012 to January 2013 for upper ureteral stone in
Mackay Memorial Hospital were included. Cases with concurrent UTI and
acute renal failure were excluded. Invisible stones, loss follow-up or con-
current middle or lower ureteral stones were also excluded. Patient age,
method of lithotripsy, stone size and burden (based on KUB or CT), ureteralcatheter insertion and further ESWL or URSL for residual stone were
recorded.
Results: There were 216 patients identiﬁed. A total of 158 patients met
criteria (118 patients in pneumatic lithoclast group and 40 patients in laser
group). One hundred and seventy-eight ureteral stones (135 in pneumatic
lithoclast group and 43 in laser group respectively) were treated. Themean
age of pneumatic lithoclast and laser group was 53.5years (22-92 years)
and 52.9 years (21-69 years) respectively. The stone size and burden in
both groups were similar (p ¼ 0.44 and 0.45 respectively). There was a
mild trend of better stone free rate and lower secondary intervention rate
in laser group (p¼ 0.07 and p ¼ 0.09 respectively). No severe complication
(>Grade III Clavien classiﬁcation) were observed.
Conclusions: Use of laser lithotripsy in management of upper ureteral
stonewas associatedwith lower rate of ureteral catheter insertion.We also
observed a weak association of better stone free rate and lower secondary
intervention rate in laser lithotripsy group. They were both safe pro-
cedures without major complications.
MP3-2.
DOWE NEED PROPHYLACTIC ANTIBIOTICS PRIOR TO EXTRACORPOREAL
SHOCK WAVE LITHOTRIPSY? A RANDOMIZED CONTROL TRIAL WITH
PROSPECTIVE FOLLOW-UP OF ASSOCIATED COMPLICATIONS
Yin-Buh Liu, Cheng-Hsing Hsieh, Shang-Jen Chang, Chia-Da Lin, Stephan
Yang. Division of Urology, Taipei Tzu Chi Hospital, The Buddhist Tzuchi
Medical Foundation, School of Medicine, Buddhist Tzu-Chi University,
Hualien, Taiwan
Purpose: To compare the efﬁcacy of prophylactic antibiotics in reduction
of post-surgical infections in patients undergoing extracorporeal shock
wave lithotripsy (ESWL).
Materials and methods: The study is a double-blind, prospective, ran-
domized placebo control trial. Between 2012 and 2014, patients with
preoperative sterile urine undergoing ESWL were randomly allocated by
the randomization ratio of 1:1 to receive prophylactic antibiotics with
single-dose oral levoﬂoxacin (500mg) or no treatment (control group),
respectively. Urine analysis and urine cultures were obtained between
postoperative day 5 and 7. Pyuria was deﬁned as S10 WBC/hpf. Signif-
icant bacteriuria was deﬁned as S105cfu uropathogens/ml. Febrile uri-
nary tract infection (fUTI) was deﬁned as body temperature of 38.0
Celsius degree with pyuria or signiﬁcant bacteriuria within 7 days post-
operatively.
Results: Initially, 274 patents underwent randomization with 139 and 135
patients in the control and levoﬂoxacin group, respectively. Finally, 206
patients (106 with placebo and 100 with levoﬂoxacin) with complete
followup of urine analysis were eligible for analysis. The rates of post-
operative pyuria were not signiﬁcantly different in patients with and
without prophylaxis (8% vs. 4.7% p ¼ 0.33). There was also no signiﬁcant
difference in rates of bacteriuria in patients with and without prophylaxis
(0% v.s. 1%, p¼ 0.49). Patients without followup of urine analysis and urine
culture were contacted with telephone and there was only patients with
post-operative fever in the levoﬂoxacin group (0% vs. 0.7%, p ¼ 0.49). As
preliminary results of the interim analysis revealed no beneﬁt of levo-
ﬂoxacin in preventing post-ESWL pyuria, bacteriuria and febrile urinary
tract infection, we terminated the study early before pre-planned sample
size is achieved.
Conclusion: The incidence of asymptomatic and febrile urinary tract
infection is low in patient underwent ESWL with pre-operative sterile
urine. Therefore, prophylactic antibiotics in these patients may be
unnecessary.
MP3-3.
EXPERIENCE OF TUBELESS PERCUTANEOUS NEPHROLITHOTOMY WITH
HEMOSTATIC SEALANT USE
Chi-Chih Lien 1, Yin-Ting Liu 1, Chi-Yun Lan 1, Kai-Yi Tzou 1, Su-Wei
Hu 1, Wei-Tang Kao 1, Kuan-Chou Chen 1,2. 1Department of Urology, Taipei
Medical University-Shuang Ho Hospital, Taipei, Taiwan; 2Department of
Urology, School of Medicine, College of Medicine, Taipei Medical University,
Taiwan
